Biobanking pp 31-41 | Cite as

Disaster Prevention and Recovery

  • Chon Boon EngEmail author
  • Wei Ling Tan
Part of the Methods in Molecular Biology book series (MIMB, volume 1897)


Biobanking is a costly activity that manages valuable and sometimes irreplaceable specimens. These specimens must be managed and protected carefully as the loss of specimens can destroy years of research efforts, and potentially result in reputational damage to the institution. Therefore, risk management, mitigation, and disaster recovery plans must be in place for unexpected man-made or natural disaster events that will affect biobanking operations. In this chapter, we discuss the various aspects of disaster prevention, and recovery efforts during and after of a disaster event.

Key words

Biobanks Risk management Risk mitigation Business continuity Disaster recovery Emergency response plan 


  1. 1.
    Baird PM et al (2013) How is your biobank handling disaster recovery efforts? Biopreserv Biobank 11(4):194–201CrossRefGoogle Scholar
  2. 2.
    Roswall N, Halkjær J, Overvad K, Tjønneland A (2013) Measures taken to restore the Danish Diet, Cancer and Health Biobank after flooding: a framework for future biobank restorations. Biopreserv Biobank 11(4):206–210CrossRefGoogle Scholar
  3. 3.
    Helen RM, Bridget AR (2013) Sustaining a biobank through a series of earthquake swarms: lessons learned from our New Zealand experience. Biopreserv Biobank 11(4):211–216CrossRefGoogle Scholar
  4. 4.
    Mintzer JL et al (2013) Preparedness for a natural disaster: how Coriell planned for hurricane sandy. Biopreserv Biobank 11(4):216–220CrossRefGoogle Scholar
  5. 5.
    Campbell LD et al (2012) 2012 best practices for repositories. Collection, storage, retrieval and distribution of biological materials for research. Biopreserv Biobank 10(2):79–161CrossRefGoogle Scholar
  6. 6.
    Baird PM, Frome RJ (2005) Large scale repository design. Cell Preserv Technol 3(4):256–266CrossRefGoogle Scholar
  7. 7.
    Hager R (2014) Biobanking operations: contingency planning and disaster recovery of research samples. Bioprocess J 13(1):55–58CrossRefGoogle Scholar
  8. 8.
    US FDA (2015) Guidance for industry. Part 11, Electronic records; electronic signatures—scope and application. Accessed 20 Sept 2017

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Tissue Repository, National University HospitalNational University Health SystemSingaporeSingapore

Personalised recommendations